Reporting a lethal drug interaction occurred during evaluation of insulin resistance in mice polycystic ovary model

Ahmadi M, Rostamzadeh A, Fathi F, Mohammadi M, Rezaie MJ. The effect of melatonin on histological changes of ovary in induced polycystic ovary syndrome model in mice. Middle East Fertil Soc J. 2017; 22: 255-59.

Ahmadi SAY, Tavafi M, Ahmadi PS. A critical approach to administration of low-dose aspirin (LDA) to improve implantation success. Int J Women's Health Reprod Sci. 2015; 3: 223-24.

Borna S, Akbari S, Eftekhar T, Mostaan F. Cushing's syndrome during pregnancy secondary to adrenal adenoma. Acta Medica Iranica. 2012; 50: 76.

Boroujeni MB, Boroujeni NB, Gholami M. The effect of progesterone treatment after ovarian induction on endometrial VEGF gene expression and its receptors in mice at pre-implantation time. Iranian J Basic Med Sci. 2016; 19: 252.

Kalhori Z, Azadbakht M, Bazdar A, Zeinali H. Polycystic ovary induction in mouse by testosterone enanthate. J Fasa Univ Med Sci. 2014; 3: 387-91.

Kapoor D, Goodwin E, Channer K, Jones T. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006; 154: 899-906.

Keshavarz M, Moradi S, Emami Z, Rohani F. Association between serum 25(OH) vitamin D and metabolic disturbances in polycystic ovary syndrome. Neth J Med. 2017; 5: 191-96.

Yari F, Aeinfar K, Abbaszadeh S, Anbari K, Ahmadi SAY. Polycystic ovary syndrome is affected and protected by DD and DI genotypes of angiotensin converting enzyme, respectively: An update of a meta-analysis. Int J Women's Health Reprod Sci. 2017; 5: 164-70.